Mono Praecimed (Paracetamol)

Paracetamol, the active ingredient in Mono Praecimed, is a Analgesic presented as a rectal formulation for Rectal use. It treats pain and fever in adults and children. GNH USA supplies Mono Praecimed as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Paracetamol acts as an analgesic and antipyretic, reducing discomfort and elevated temperature. - Pain: provides relief of mild to moderate pain such as musculoskeletal or dental discomfort. - Fever: lowers elevated body temperature associated with infection or inflammation. - Headache: alleviates tension‑type headache and other common headache disorders.

Paracetamol is generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Nausea: mild stomach upset or queasiness. - Rash: skin redness or mild itching. - Abdominal discomfort: transient stomach pain. - Elevated liver enzymes: mild, often reversible changes. - Dizziness: occasional light‑headed feeling.

Serious or Rare Side Effects: - Hepatotoxicity: severe liver injury, especially with overdose. - Stevens‑Johnson syndrome: rare severe skin reaction. - Anaphylaxis: life‑threatening allergic response. - Blood dyscrasias: rare cases of agranulocytosis or thrombocytopenia. - Hypotension: uncommon sudden drop in blood pressure.

Paracetamol should be used with awareness of specific safety considerations. - Do not exceed recommended total daily dose: adhere to label limits to avoid toxicity. - Use caution in liver disease: patients with hepatic impairment may need dose adjustment. - Avoid alcohol: concurrent intake increases risk of liver injury. - Verify concurrent products: ensure no other paracetamol‑containing medicines are taken simultaneously. - Store at room temperature: keep in the original pack, protect from moisture and direct sunlight.

Paracetamol can interact with several medicines, requiring attention to avoid adverse outcomes.

Major Interactions (Avoid): - Warfarin: may increase anticoagulant effect and bleeding risk. - Alcohol: combined use heightens risk of hepatotoxicity. - Enzyme‑inducing anticonvulsants (e.g., carbamazepine, phenytoin): can reduce paracetamol effectiveness.

Moderate Interactions (Monitor Closely): - Oral contraceptives: may slightly increase plasma levels of paracetamol. - Isoniazid: can potentiate liver toxicity. - Antiretroviral agents (e.g., ritonavir): may alter metabolism, requiring monitoring.